Bassel El-Rayes, MD, reviews the case of a 66-year old man with gastric carcinoma and discusses the disease from diagnosis to unmet needs.
EP. 1: Patient Case With HER2+ Gastric Carcinoma
Watch
EP. 2: Molecular Testing for Gastric Carcinoma
EP. 3: Treatment Options for Gastric Carcinoma
EP. 4: The DESTINY-Gastric01 Trial and Mechanisms of Resistance in Gastric Carcinoma
EP. 5: Future Directions and Unmet Needs for Gastric Carcinoma
EP. 6: Trastuzumab Deruxtecan for HER2+ Gastric Cancer
Bassel El-Rayes, MD, an expert in oncology, discusses the DESTINY-Gastric01 trial of trastuzumab deruxtecan in HER2+ gastric cancer and comments on implications for second-line treatment and beyond.